JPMorgan Chase & Co’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-73,726
Closed -$445K 4976
2019
Q4
$445K Sell
73,726
-485,586
-87% -$2.93M ﹤0.01% 3476
2019
Q3
$2.01M Sell
559,312
-130,257
-19% -$469K ﹤0.01% 2727
2019
Q2
$1.84M Buy
689,569
+125,310
+22% +$333K ﹤0.01% 2720
2019
Q1
$1.67M Sell
564,259
-428,455
-43% -$1.27M ﹤0.01% 2745
2018
Q4
$1.58M Sell
992,714
-46,724
-4% -$74.3K ﹤0.01% 2788
2018
Q3
$3.83M Buy
1,039,438
+69,270
+7% +$255K ﹤0.01% 2401
2018
Q2
$2.75M Sell
970,168
-64,465
-6% -$182K ﹤0.01% 2614
2018
Q1
$3.84M Sell
1,034,633
-124,424
-11% -$462K ﹤0.01% 2379
2017
Q4
$3.34M Buy
1,159,057
+993,581
+600% +$2.86M ﹤0.01% 2489
2017
Q3
$723K Sell
165,476
-683,860
-81% -$2.99M ﹤0.01% 3069
2017
Q2
$3.9M Buy
849,336
+297,992
+54% +$1.37M ﹤0.01% 2266
2017
Q1
$2.32M Buy
551,344
+102,374
+23% +$431K ﹤0.01% 2532
2016
Q4
$1.85M Buy
448,970
+319,591
+247% +$1.32M ﹤0.01% 2711
2016
Q3
$1.05M Sell
129,379
-604,860
-82% -$4.9M ﹤0.01% 2736
2016
Q2
$5.73M Sell
734,239
-328,516
-31% -$2.56M ﹤0.01% 1939
2016
Q1
$8.21M Sell
1,062,755
-44,218
-4% -$341K ﹤0.01% 1695
2015
Q4
$11.9M Sell
1,106,973
-14,320
-1% -$155K ﹤0.01% 1498
2015
Q3
$7.75M Buy
1,121,293
+246
+0% +$1.7K ﹤0.01% 1724
2015
Q2
$9.93M Buy
1,121,047
+484,276
+76% +$4.29M ﹤0.01% 1699
2015
Q1
$6.28M Buy
636,771
+293,829
+86% +$2.9M ﹤0.01% 1974
2014
Q4
$4.2M Buy
342,942
+251,104
+273% +$3.08M ﹤0.01% 2139
2014
Q3
$916K Buy
+91,838
New +$916K ﹤0.01% 2793
2013
Q4
Sell
-49,669
Closed -$150K 3849
2013
Q3
$150K Sell
49,669
-239,196
-83% -$722K ﹤0.01% 3713
2013
Q2
$2.36M Buy
+288,865
New +$2.36M ﹤0.01% 2440